{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:01:33Z","timestamp":1791082893212,"version":"4.1.0"},"reference-count":31,"publisher":"American Chemical Society (ACS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Res. Toxicol."],"published-print":{"date-parts":[[2006,5,1]]},"DOI":"10.1021\/tx050317i","type":"journal-article","created":{"date-parts":[[2006,5,15]],"date-time":"2006-05-15T04:25:59Z","timestamp":1147667159000},"page":"701-709","source":"Crossref","is-referenced-by-count":113,"title":["Kinetics of Acetaminophen Glucuronidation by UDP-Glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential Implications in Acetaminophen\u2212Induced Hepatotoxicity"],"prefix":"10.1021","volume":"19","author":[{"given":"Abdul E.","family":"Mutlib","sequence":"first","affiliation":[{"name":"Departments of Pharmacokinetics, Dynamics and Metabolism, and Safety Sciences, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theunis C.","family":"Goosen","sequence":"additional","affiliation":[{"name":"Departments of Pharmacokinetics, Dynamics and Metabolism, and Safety Sciences, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan N.","family":"Bauman","sequence":"additional","affiliation":[{"name":"Departments of Pharmacokinetics, Dynamics and Metabolism, and Safety Sciences, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"Williams","sequence":"additional","affiliation":[{"name":"Departments of Pharmacokinetics, Dynamics and Metabolism, and Safety Sciences, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaila","family":"Kulkarni","sequence":"additional","affiliation":[{"name":"Departments of Pharmacokinetics, Dynamics and Metabolism, and Safety Sciences, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seva","family":"Kostrubsky","sequence":"additional","affiliation":[{"name":"Departments of Pharmacokinetics, Dynamics and Metabolism, and Safety Sciences, Pfizer Inc., 2800 Plymouth Road, Ann Arbor, Michigan 48105"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2006,3,25]]},"reference":[{"key":"tx050317ib00001\/tx050317ib00001_1","volume-title":"Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes. Toxicol. Sci. 87, 146\u2212155","author":"Kostrubsky S. E.","year":"2005"},{"key":"tx050317ib00002\/tx050317ib00002_1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0041-008X(92)90220-M","volume":"117","author":"De Morais S. M.","year":"1992","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"tx050317ib00003\/tx050317ib00003_1","volume-title":"Biochem. Pharmacol. 45","author":"Bock K. W.","year":"1993"},{"key":"tx050317ib00004\/tx050317ib00004_1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/abbi.1997.0485","volume":"350","author":"Munzel P. A.","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"tx050317ib00005\/tx050317ib00005_1","doi-asserted-by":"crossref","unstructured":"Fisher, M. B., Vandenbranden, M., Findlay, K., Burchell, B., Thummel, K. E., Hall, S. D., and Wrighton, S. A. (2000) Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity:\u2009 Relationship between UGT1A1 promoter genotype and variability in a liver bank.Pharmacogenetics10, 727\u2212739.","DOI":"10.1097\/00008571-200011000-00007"},{"key":"tx050317ib00006\/tx050317ib00006_1","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(24)29222-3","volume":"299","author":"Court M.","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx050317ib00007\/tx050317ib00007_1","volume-title":"Enzyme Kinetics:\u2009 Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems","author":"Segel I. H.","year":"1975"},{"key":"tx050317ib00008\/tx050317ib00008_1","volume":"294","author":"Mutlib A. E.","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx050317ib00009\/tx050317ib00009_1","volume-title":"Use of human hepatcoytes to study P450 gene induction. Methods Enzymol. 272, 388\u2212401","author":"Strom S.","year":"1996"},{"key":"tx050317ib00010\/tx050317ib00010_1","volume-title":"The role of conjugation on hepatotoxicity of troglitazone in human and porcine hepatocyte cultures. Drug Metab. Dispos. 28, 1192\u22121197","author":"Kostrubsky V. E.","year":"2000"},{"key":"tx050317ib00011\/tx050317ib00011_1","volume-title":"Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes. Drug Metab. Dispos. 30, 977\u2212984","author":"Wen Y. H.","year":"2002"},{"key":"tx050317ib00012\/tx050317ib00012_1","volume-title":"The use of human hepatocytes cultures to study the induction of cytochrome P-450. Drug Metab. Dispos. 27, 887\u2212894","author":"Kostrubsky V. E.","year":"1999"},{"key":"tx050317ib00013\/tx050317ib00013_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1006\/taap.1996.8023","volume":"142","author":"Kostrubsky V. E.","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"tx050317ib00014\/tx050317ib00014_1","volume-title":"Stable expression of a human liver UDP-glucuronosyl transferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab. Dispos. 22, 799\u2212805","author":"Green M. D.","year":"1994"},{"key":"tx050317ib00015\/tx050317ib00015_1","volume-title":"UDP glucuronosyl transferase mRNA levels in human liver disease. Drug Metab. Dispos. 30, 129\u2212134","author":"Congiu M.","year":"2002"},{"key":"tx050317ib00016\/tx050317ib00016_1","volume-title":"Isolation and characterization of UGT2B15(y-85):\u2009 A UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7, 317\u2212325","author":"Levesque E.","year":"1997"},{"key":"tx050317ib00017\/tx050317ib00017_1","volume-title":"T2B7 (H268Y) and UGT2B15 (D85Y). Cancer Epidemiol. Biomarkers Prev. 9, 329\u2212333.","author":"Lampe J. W.","year":"2000"},{"key":"tx050317ib00018\/tx050317ib00018_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2165\/00129785-200303010-00006","volume":"3","author":"Burchell B.","year":"2003","journal-title":"Am. J. Pharmacogenomics"},{"key":"tx050317ib00019\/tx050317ib00019_1","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.104.067660","volume":"310","author":"Court M. H.","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx050317ib00020\/tx050317ib00020_1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clpt.2005.02.006","volume":"77","author":"Chung J. Y.","year":"2005","journal-title":"Clin. Pharmacol. Ther."},{"key":"tx050317ib00021\/tx050317ib00021_1","volume-title":"Paracetamol overdosage:\u2009 Pharmacological considerations and clinical management. Drugs 25, 290\u2212314","author":"Prescott L.","year":"1993"},{"key":"tx050317ib00022\/tx050317ib00022_1","volume-title":"Molecular mechanisms of the hepatotoxicity caused by acetaminophen. Semin. Liver Dis. 10, 267\u2212278","author":"Nelson S. D.","year":"1990"},{"key":"tx050317ib00023\/tx050317ib00023_1","volume":"24","author":"Vermeulen N. P. E.","year":"1992","journal-title":"Drug Metab. Rev."},{"key":"tx050317ib00024\/tx050317ib00024_1","volume-title":"Long-term anticonvulsant therapy worsens outcome in paracetamol-induced fulminant hepatic failure. Hum. Exp. Toxicol. 11, 265\u2212270","author":"Bray G. P.","year":"1992"},{"key":"tx050317ib00025\/tx050317ib00025_1","volume-title":"A case of paracetamol retard poisoning with fatal outcome. Ugeskr Laeger. 157, 899\u2212900","author":"Lystbaek B. B.","year":"1995"},{"key":"tx050317ib00026\/tx050317ib00026_1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/096032718800700106","volume":"7","author":"Minton N. A.","year":"1988","journal-title":"Hum. Toxicol."},{"key":"tx050317ib00027\/tx050317ib00027_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.7326\/0003-4819-101-3-403_1","volume":"101","author":"Pirotte J.","year":"1984","journal-title":"Ann. Intern. Med."},{"key":"tx050317ib00028\/tx050317ib00028_1","volume":"234","author":"Abernethy D. R.","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx050317ib00029\/tx050317ib00029_1","volume-title":"The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem. Pharmacol. 65, 1441\u22121449","author":"Ethell B.","year":"2003"},{"key":"tx050317ib00030\/tx050317ib00030_1","volume-title":"Glucuronidation of acetaminophen catalyzed by multiple rat phenol UDP-glucuronosyltransferases. Drug Metab. Dispos. 30, 324\u2212330","author":"Kessler F. K.","year":"2002"},{"key":"tx050317ib00031\/tx050317ib00031_1","volume":"17","author":"Ulrich D.","year":"1987","journal-title":"Eur. J. Clin. Invest."}],"container-title":["Chemical Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/tx050317i","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T23:54:03Z","timestamp":1736380443000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/tx050317i"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,25]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,5,1]]}},"alternative-id":["10.1021\/tx050317i"],"URL":"https:\/\/doi.org\/10.1021\/tx050317i","relation":{},"ISSN":["0893-228X","1520-5010"],"issn-type":[{"value":"0893-228X","type":"print"},{"value":"1520-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,25]]}}}